Our People

Thomas Unger, PhD Strategic Advisor

Dr. Unger is the Chief Strategy Officer of Naia Limited, a drug development company he co-founded in 2015. Previously, he was at Pfizer Inc. where he held a number of senior roles within the Development Operations and Worldwide Regulatory Strategy organizations. He was the head of strategy for Pfizer’s Biotherapeutics and Bioinnovation Center (BBC). He joined Pfizer as a senior director in the Strategic Management Group within Pfizer Global Research and Development (PGRD) where he was a member of the Development Leadership Team and responsible for leading strategic and operational initiatives within the R&D organization. While at Pfizer, Dr. Unger was responsible for initiating several innovative efforts that spanned business strategy, operational change and clinical development programs. He also was responsible for initiating a number collaborative innovation initiatives, including co-founding MIT’s NEW Drug Development ParaDIGmS (NEWDIGS) program, for which he serves as a member of the Executive Committee and senior advisor.

Before joining Pfizer, Dr. Unger held a number of senior strategic advisory positions including at the investment banking firm Aperion Partners, LLC and MTM Advisors, LLC, and the management consulting firms Wood Mackenzie Limited and PA Consulting Group. He started his industry career as co-founder of a number of early- stage biotechnology companies including BioLogic Technologies and Miragen Incorporated. He serves on the advisory boards of a number of emerging biotech companies and foundations.

Dr. Unger earned his Ph.D. in Biological Sciences from the California College of Medicine, University of California, Irvine and his M.B.A. from the Marshall School of Business, University of Southern California.

Back to All